Nivolumab and Eribulin in HER2 Negative Metastatic Breast Cancer

NCT04061863 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
90
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Seoul National University Hospital

Collaborators